
Sotatercept Phase 3 Program Design and Rationale: A Novel Treatment for Pulmonary Arterial Hypertension
This study was presented by Dr. Ioana R Preston, Tufts Medical Center, Boston, MA; on th Sunday November 14 at

This study was presented by Dr. Ioana R Preston, Tufts Medical Center, Boston, MA; on th Sunday November 14 at

This study was presented by Dr Mahmoud El Iskandarani, from the St Mary’s Regional Medical Center, Lewiston, on Sunday th

This study was presented on Sunday 14 November at the 2021 American Heart Association (AHA) Scientific Sessions held virtually by

This study was presented by Dr. Marko Banovic, M.D., Ph.D., lead investigator of the trial and an associate professor of

This study was presented by Dr. James S. Gammie, M.D et al., on Saturday 13th November at the 2021 Annual

This study was presented by Drs. Marie Lordkipanidze, Ph.D., B.Pharm.; Fraser Rubens, M.D., M.Sc. on Saturday 13th November at the

This study was presented by Drs. Yuan Lu et al., from the Yale University, New Haven, CT, on th Saturday

This study was presented by Dr. Wei Hu, th Shanghai, et al., on Saturday 13 November at the 2021 Annual

This study was presented by Dr. Wei Hu, th Shanghai, et al., on Saturday 13 November at the 2021 Annual

This study was presented by Dr. Alejandro De La Sierra, Hospital Mutua Terrassa, Terrassa, th Spain, et al., on Saturday